Foreword Contributor
CREATE IN THE NOW: From Dream to Enhavim
Ardy Arianpour shares his perspective on healthcare innovation and the power of enhavim.
Ardy Arianpour
Thank you, Ardy, for your powerful foreword that bridges healthcare innovation with the enhavim framework.
Your recognition of Sherrie Rose's insights on holding multiple time horizons simultaneously validates the practical application of this framework in building companies that create lasting impact.
Your work transforming healthcare through patient-centric data interoperability demonstrates what becomes possible when vision, purpose, and mission work together.
From the Foreword
"Sherrie Rose makes me ponder: What will healthcare look like when today's newborns turn 100?"
Ardy opens his foreword with this question, reflecting the long-term thinking that has defined his career in healthcare innovation. He challenges readers to think beyond immediate product launches and quarterly results, asking instead what infrastructure we need to build today for the healthcare of tomorrow.
"Healthcare's biggest challenges weren't medical or scientific. They were data, access, and the failure to connect information across time."
This realization, gained from his early work at the Salk Institute, became the foundation for two decades in genomics and health technology—culminating in SEQSTER's patient-centric data interoperability platform.
"Innovation is meaningless without execution. Sherrie has given you both the vision and the practical system to execute it."
Healthcare Data Pioneer and Patient Advocate
Ardy Arianpour is CEO and Co-Founder of SEQSTER, the leading patient-centric healthcare technology company that breaks down health data silos at scale. With over 20 years driving innovation in life sciences, genomics, and digital health, Ardy is a visionary health tech executive with an unwavering commitment to advancing patient rights and introducing transformative technologies that positively impact lives at scale.
Early Recognition and Foundation
Ardy's exceptional talent was recognized early. At 18, the Chicago Tribune called him an "investment prodigy." TIME magazine featured his work in their first story on online investing in 1998. During high school, he landed his first science-related job at the Salk Institute in Dr. Ron Evans' lab, where he gained insights that would shape his career trajectory.
What he observed at the Salk Institute helped him realize that healthcare's biggest challenges weren't purely medical or scientific. They were about data, access, and the failure to connect information across time. This realization became the foundation for his life's work.
Genomics Pioneer and Industry Leader
Ardy's career in genomics and health technology spans two decades of breakthrough innovation. As Senior Vice President of Ambry Genetics, he helped launch the first commercial clinical exome sequencing test, building a company that sold to Konica for $1 billion in 2017. As Chief Commercial Officer of Pathway Genomics, he established programs that provided nearly $10 million in free BRCA testing for those who couldn't afford it.
These experiences revealed a consistent pattern: breakthrough healthcare innovation requires thinking across decades, not quarters. As a key player in the 2013 landmark Supreme Court decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access, benefiting patients and family members across the country.
"Health data is medicine."
This philosophy drives everything Ardy does, from building enterprise technology to advocating for patient rights.
Founding SEQSTER: Breaking Down Healthcare Data Silos
In 2016, Ardy founded SEQSTER with a clear mission: to positively impact patient lives at scale by removing the barriers to health data access. The problem was clear—healthcare generates massive amounts of data, but it sits in silos. A patient's complete health story gets fragmented across providers, devices, and systems, making it nearly impossible for anyone to see the full picture.
Patient-centric data interoperability became Ardy's singular focus. SEQSTER's operating system aggregates disparate health data sources into a single, 360-degree view of a patient in real-time, solving challenges that have plagued healthcare for decades. The platform provides nationwide coverage of electronic health records from hospitals and medical groups, genomic DNA data, wearables, pharmacy records, and social determinants of health data.
Through its customizable white-label approach, SEQSTER delivers accelerated access to de-identified, tokenized, real-time data and comprehensive curated data to address critical needs across the healthcare continuum—from clinical trials to patient engagement to research acceleration.
"SEQSTER is improving healthcare and transforming it. By empowering patients and accelerating research, we're pushing the boundaries of what's possible. This isn't just progress, it's a fundamental shift in how we think about health, data, and the future with the patient at the center."
— Ardy Arianpour
The impact is measurable: for the first time, users create their own matched, longitudinal health data profile across all of their US-based healthcare data sources. What once took weeks or months—gathering medical records from multiple providers—now happens in minutes. This breakthrough in data interoperability enables faster clinical trial recruitment, more comprehensive research, and truly patient-centered care.
Endorsing the Time Horizons Framework
In his foreword, Ardy recognizes Sherrie Rose's framework for holding multiple time horizons simultaneously. When building enterprise technology that aggregates health data in real-time, he operates at several levels at once—imagining healthcare a century from now, thinking in decades about infrastructure, planning annual milestones, managing monthly sprints, and executing daily.
As Ardy writes: "Sherrie Rose has articulated what I've practiced building companies: the discipline of holding multiple time horizons simultaneously." This multi-level perspective is what allows SEQSTER to build lasting value rather than chase short-term metrics into irrelevance.
Recognition and Impact
Ardy's visionary leadership has earned widespread recognition:
2019 Top 40 Healthcare Transformer and Innovation Catalyst by a leading media brand's honor roll of visionaries working to bring change to the $3 trillion healthcare industry.
San Diego Business Journal 40 Under 40 and CEO of the Year Awards Finalist, recognizing local industry leaders' achievements within their companies and the community.
CB Insights Digital Health 150 (2021, 2022, and multiple years), selecting SEQSTER from a pool of over 13,000 private companies as one of the most promising digital health companies in the world.
Inside Precision Medicine Advisory Board (2024), joining luminaries from healthcare, technology, and life sciences in advancing precision medicine.
American Heart Association Health Tech Competition (2018), where SEQSTER won both Judges' and People's Choice Awards—the first time in the competition's history a company received both honors.
Discovering Enhavim: The Missing Integration
For years, Ardy talked about SEQSTER's mission. The company had a mission statement, a clear purpose, and defined goals. But something felt disconnected—these were separate forces pulling in different directions rather than a unified driving force.
When Sherrie Rose introduced him to the concept of enhavim, the missing piece fell into place. Enhavim integrates purpose and mission, led by vision. Not mission alone. Not purpose in isolation. But all three working together, with vision setting the direction.
As Ardy reflects in his foreword: "That's how a dream becomes reality. That's what keeps you going when obstacles get in the way. That's the difference between trend chasers and companies that create real change."
This integration explains why SEQSTER has remained focused on patient-centric data interoperability while others pivoted to follow trends. The vision (healthcare where patients own their data), the purpose (removing barriers to health data access), and the mission (building technology that scales this access) work together as one unified force.
In his foreword, Ardy writes: "This book provides the framework I wish I'd had twenty years ago. The time-level system shows you how to zoom from century vision to daily execution without losing coherence. The enhavim concept explains why some organizations build lasting value while others chase short-term metrics into irrelevance."
Education and Leadership Philosophy
Ardy earned his Bachelor of Science in Biological Sciences from the University of California, Irvine, and his MBA from the Marshall Goldsmith School of Management. Throughout his career, he has demonstrated the rare combination of strategic vision, relentless work ethic, and generous spirit—all traits of transformative leadership.
His philosophy is clear: Innovation is meaningless without execution. Breakthrough healthcare innovation requires vision that extends beyond immediate product launches into how healthcare will function for the next generation. And at the center of it all must be the patient.
SEQSTER in Action
Learn how SEQSTER is transforming healthcare through patient-centric data interoperability
